Sort
40,608 grants matching “prostate cancer”
Intermittent Fasting using a Fasting-Mimetic Diet to Improve Prostate Cancer Control and Metabolic Outcomes
$722,345Stephen Jay Freedland · Cedars-Sinai Medical Center · R01 · FY2023 · CA
Recovery Support for Bladder CA Patients and Caregivers: A Multimodal Approach
$722,281Michael A Diefenbach · Feinstein Institute For Medical Research · R01 · FY2018 · CA
Functional Characterization and Development of Therapeutic Paradigms for DNA Damage Repair (DDR)-deficient Lethal Prostate Cancer
$722,240Goutam Chakraborty · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · CA
Carolina Community Network
$722,192Paul A. Godley · Univ Of North Carolina Chapel Hill · U01 · FY2009 · CA
Improving Quality of Life of Prostate Cancer Survivors with Androgen Deficiency
$721,908Shalendar Bhasin · Brigham And Women'S Hospital · R01 · FY2022 · AG
GCDH Addiction in Melanoma
$721,672Ze'ev A Ronai · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2023 · CA
Selenium and Vitamin E Chemoprevention Trial (SELECT
$721,474La Biomed Res Inst/ Harbor Ucla Med Ctr · M01 · FY2004 · RR
HEREDITARY X-LINKED TUMOR SUPPRESSOR ESCAPES IMMUNE CONTROL IN PROSTATE CANCER
$721,426Health Research, Inc. · · FY2019 · Defense Health Agency
Computational Methods for Identifying Non-coding Cancer Drivers
$721,394Ekta Khurana · Weill Medical Coll Of Cornell Univ · R01 · FY2020 · CA
Early Detection Research Network (EDRN) BiomarkerReferenceResourceCenter (BRRC)
$721,387National Cancer Institute · Y01 · FY2010 · CA
Improving Patient-Important Outcomes with Testosterone Replacement in Hypogonadal Men with a Prior History of Cancer
$720,928Jose M. Garcia · Seattle Inst For Biomedical/Clinical Res · R01 · FY2019 · CA
Prostate Cancer Biomarker and Imaging Validation Alliance: Emory University, University of Alabama Birmingham, and University of Texas Southwestern
$720,852Martin G Sanda · Emory University · U01 · FY2023 · CA
Tumor Growth and Microenvironment Influence T Cell Tolerance to Tumor Antigens
$720,716Arthur Hurwitz · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Restore: Improving Sexual Outcomes of Gay and Bisexual Prostate Cancer Survivors
$720,659B. R. Simon Rosser · University Of Minnesota · R01 · FY2018 · CA
TARGETING KINASES IN PROSTATE CANCER
$720,630The Trustees Of Columbia University In The City Of New York · · FY2011 · Department of the Army
Role of Novel Cytokine-like Molecule Secretoglobin (SCGB) 3A2 in Lung
$720,526Shioko Kimura · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Optimizing Treatment of Prostate Cancer in Men living with HIV
$720,465Keith Magnus Sigel · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · CA
Theranostic DLL3/PSMA-bi-specific CAR-T cells for prostate cancer therapy
$720,416Vladimir Ponomarev · Sloan-Kettering Inst Can Research · R01 · FY2024 · CA
Characterizing genetic risk of cancer across diverse populations through multi-ancestry epigenome profiling and chromatin QTL discovery
$720,252Sylvan C. Baca · Dana-Farber Cancer Inst · U01 · FY2025 · CA
FREQUENT LOSS OF CHD1 IN THE PROSTATE CANCER OF AFRICAN AMERICANS AND ITS POTENTIAL ROLE IN INCREASED SENSITIVITY TO PLATINUM OR PARP INHIBITOR-BASED
$720,195Children'S Hospital Corporation, The · · FY2018 · Defense Health Agency
Augmenting PSMA expression to enhance PSMA directed therapeutic efficacy
$720,165Michael C Haffner · Fred Hutchinson Cancer Center · R37 · FY2024 · CA
PEPTIDE BEAD MICROARRAYS MEASURED BY MASS SPECTROMETRY IMAGING
$720,069Vladislav Bergo · Adeptrix Corporation · R44 · FY2016 · GM
IDENTIFICATION OF EPIGENETIC CHANGES IN PROSTATE CANCER USING INDUCED PLURIPOTENT STEM CELLS
$720,034The Leland Stanford Junior University · · FY2010 · Department of the Army
Translational Pathology Core Facility
$719,937Sue Ellen Martin · University Of Southern California · P30 · FY2008 · CA
PSMAâs enzymatic activity as new target for Prostate Cancer diagnosis and therapy
$719,857Jan Grimm · Sloan-Kettering Inst Can Research · R01 · FY2022 · CA